Mandavia to be pivotal in govt plans to manage Covid, lift country's image

Mandaviya is also seen as industrious and resourceful in his home state

Mansukh Mandaviya, Health Minister
Mansukh Mandaviya, Union Health Minister
Aditi PhadnisVinay Umarji New Delhi/Ahmedabad
3 min read Last Updated : Jul 09 2021 | 6:10 AM IST
In April-May, when the second wave of Covid-19 was at its peak and the leadership of the Bharatiya Janata Party (BJP) was deeply troubled about facing people amid massive vaccine and oxygen shortages, Mansukh Mandaviya stepped into the breach.

Armed with a detailed PowerPoint presentation, the minister — who was then minister of state of shipping with charge of chemicals and fertilisers — explained to BJP office-bearers India’s plans for eventual self-sufficiency in vaccines, and more immediately, how they must be distributed to meet shortages. These were temporary measures, he assured office-bearers calmly, and showed with data how Indian vaccine production would be ramped up at a time when even supply of Active Pharmaceutical Ingredients (APIs) from China and the US was under question. 

“I came away from that meeting feeling much more reassured,” said an office-bearer who attended. “He (Mandaviya) obviously knew what he was talking about because of the facts and the data he presented. He told us how vaccines were being produced, what he was going to do about raw materials, what the time line was… I felt he was in command of the situation.” The person added: “He might not be articulate or be able to speak English well. But I judged him to be highly intelligent.”

This much is clear: that Mandaviya is no vote catcher. He’s been a Rajya Sabha MP, though he was an MLA in the Gujarat Assembly from 2002 to 2007. He’s not known to give fiery speeches or stirring public addresses. But he has been involved in Gujarat issues, intervening in his own way when he could. He has taken a keen interest in the state’s affairs, especially in assisting industries. For instance, in the aftermath of the implementation of the GST, it was Mandaviya as part of the Centre’s GST task force who mediated with the textile industry after traders called a strike in protest of the new regime.

“It was his mediation along with other ministers from the state that saw the textile industry being placated. The industry had also sought simplification of the tax structure given the multiple stages of production in the textile value chain, which he took up with the Centre and the then FM,” said Ashish Gujarati, president-elect of the South Gujarat Chamber of Commerce and Industry (SGCCI).

Mandaviya is also seen as industrious and resourceful in his home state. According to a former bureaucrat in Gujarat, it was Mandaviya’s involvement as MoS for ports and shipping that is believed to have brought INS Vikrant to the Alang ship breaking yard’s shores. “He has tried to stay as relevant as possible since his early political days in Gujarat and has tried to be resourceful in doing so,” the former bureaucrat told Business Standard on condition of anonymity.

Mandaviya is going to be pivotal in the government’s plans to manage not just the pandemic but also India’s image in the eyes of its own citizens. The second is easier to handle. Mandaviya’s pitch to party leaders and anyone who is listening is: India is a victim of the global pharma lobby and needs to develop its own vaccine and API resources.

“It is not just the pharma patents regime — what worried the lobbyists of big pharma was India’s open licensing policy. So we have to depend on ourselves,” said a BJP leader who attended the presentation. 

Mandaviya has factored this in his strategy. The health ministry may, from now on, only nominally be for the health of Indians — it might be known better for the vaccination of Indians.

One subscription. Two world-class reads.

Already subscribed? Log in

Subscribe to read the full story →
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

Topics :Mansukh Lal MandaviyaBharatiya Janata PartyHealth Ministry

Next Story